Leucaemia myeloides acuta
 |
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
Leucaemia myeloides acuta (ICD-10: G92.0[1]) est morbus sanguinis cum proliferatione et differentiatione praecursorum medullae ossium sine functione in cellulas immaturas haematopoieticas[2].
Ad leucaemiam myeloides acutam tractandam chemotherapia pernecesse est. Scopus tractationis est adventus remissionis. Effectus chemotherapiae redigantur resistentia contra medicamenta, metastasi et relapso causa. Radiotherapia quoque et transplantatio medullae ossium tractationis in usu sunt.
Adhuc (anno 2015) in orbe terrarum decies centena milia homines aegri erant et 147,000 deciderunt[3].
Notae[recensere | fontem recensere]
- ↑ Referentia nominis Latina.
- ↑ Xu DD Wang Y, Zhou PJ, Qin SR, Zhang R, Zhang Y, Xue X, Wang J, Wang X, Chen HC, Wang X, Pan YW, Zhang L, Yan HZ, Liu QY, Liu Z, Chen SH, Chen HY, Wang YF (2018). "The IGF2/IGF1R/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells". Front Pharmacol 9 (678)
- ↑ GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet 388 (10053): 1545-602
Nexus interni
Nexus externi[recensere | fontem recensere]
- Institutum cancrorum nationale de epidemiologia. (Anglice)